Prison Interventions and HIV Prevention Collaboration
Project Number5R01DA029910-12
Former Number2R01DA029910-11
Contact PI/Project LeaderALTICE, FREDERICK LEWIS
Awardee OrganizationYALE UNIVERSITY
Description
Abstract Text
Eastern Europe and Central Asia (EECA) have among the highest (5 of the top 10) incarceration rates
worldwide, with staggering numbers of people who inject drugs (PWID), mostly with opioid use disorder (OUD:
82%) and HIV (PWH: 18%). The HIV epidemic in EECA is primarily concentrated in PWID, who account for 56%
of new HIV infections with a high HIV prevalence among PWID (7.3-53.4%). The prisons and probation settings
provide an opportunity for HIV prevention using opioid agonist therapies (OAT). The newly (past 5 years) formed
probation system in these countries presents new opportunities and challenges for HIV prevention as probation
does not have an international mandate to ensure human rights access to HIV prevention and treatment.
This proposal builds on our existing implementation science network in several EECA countries. Specifically,
first, MAT-LINK used SBIRT (screening, brief intervention, and referral to treatment) with trained researchers to
pilot test a strategy to scale-up opioid agonist therapies. Second, many EECA countries have recently introduced
probation, providing opportunities to ensure access to trans-institutionalized persons in probation to better align
public health with public safety. Third, real-world implementation using existing infrastructure and staffing across
more sites is now needed to expand OAT throughout prisons and probation. Fourth, we developed the first
Project ECHO in EECA to guide OAT integration into primary care and psychiatric care into OAT settings.
We have successfully used the EPIS (Explore, Prepare, Implement and Sustain) framework combined with
the NIATx model of process improvement to scale-up OAT. Also using EPIS, we used Project ECHO to integrate
OAT and HIV care into primary care clinics in Ukraine to teach specialized care to non-specialists, which we
propose to use to teach prison doctors. NIATx is an evidence-informed facilitation strategy with documented
successes in the adoption and scale-up of evidence-based practices (EBPs), like OAT. Using the EPIS
framework and the NIATx approach we propose to: AIM 1: Scale-up OAT as HIV prevention in prisons and pre-
trial detention in EECA and for individuals with OUD and link them to community treatment after release; and
AIM 2: Scale-up OAT as HIV prevention in the newly formed probation system in EECA and for individuals with
OUD and link them to OAT treatment as part of routine care to align public safety and public health.
We will continue using our network to achieve these goals through collaboration with our partners in EECA.
Significance is high due to the need to reduce HIV transmission in EECA where HIV, PWID and incarceration
are syndemic, which is primarily concentrated in PWID and where OAT coverage is low. Innovation is high by
using the NIATx model to scale-up OAT in prisons and probation, along with collaborative learning tools like
Project ECHO to teach and maintain skills. Feasibility is high due to longstanding collaborations between these
many collaborators and buy-in from CJS settings. Public health benefit is high due to addressing the interface of
health and justice where many of the most vulnerable exist.
Public Health Relevance Statement
Project Narrative
Prisons concentrate people who inject drugs and people living with HIV, especially in the Commonwealth of
Independent States of the former Soviet Union, where the HIV epidemic and drug injectors and their sexual
partners remains volatile. Introducing and expanding an evidence-based HIV prevention strategy like opioid
substitution therapy within the prisons in a legal, political, and cultural context is fraught with barriers that
involve the client, prison staff and the criminal justice infrastructure. Implementation science strategies are
effective approaches to study and promote intervention effectiveness that simultaneously works to overcome
barriers at each level.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS preventionAddressAdoptionCaringCentral AsiaClientCollaborationsCommonwealth of Independent StatesCommunitiesCountryCriminal JusticeEastern EuropeEducational process of instructingEffectiveness of InterventionsEnsureEpidemicEvaluationEvaluation ResearchEvidence based practiceFoundationsGoalsHIVHIV InfectionsHealthHealth BenefitHealthcareHigh PrevalenceHuman RightsImprisonmentIncidenceIndividualInfrastructureInjecting drug userInstitutionalized PersonsInternationalInterventionIntervention StudiesJusticeKyrgyzstanLearningLegalLinkModelingMoldovaOpioid replacement therapyOutcomePerformancePersonsPharmaceutical PreparationsPilot ProjectsPoliciesPoliticsPrevalencePrevention strategyPrimary CarePrisonsPsychiatric therapeutic procedurePublic HealthResearchResearch PersonnelResearch TrainingSafetyServicesSexual PartnersSiteSystemTajikistanTrainingUS StateUSSRUkraineUnited States Health Resources and Services AdministrationVolatilizationWorkbrief interventioncommunity settingevidence baseimplementation scienceimprovedinnovationinsightmortalitynext generationopioid agonist therapyopioid useopioid use disorderpilot testpreventprimary care clinicprobationprocess improvementresearch and developmentroutine carescale upscreening, brief intervention, referral, and treatmentservice deliveryskillssuccesssyndemictherapy developmenttooltransmission processuptake
No Sub Projects information available for 5R01DA029910-12
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DA029910-12
Patents
No Patents information available for 5R01DA029910-12
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DA029910-12
Clinical Studies
No Clinical Studies information available for 5R01DA029910-12
News and More
Related News Releases
No news release information available for 5R01DA029910-12
History
No Historical information available for 5R01DA029910-12
Similar Projects
No Similar Projects information available for 5R01DA029910-12